Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
出版年份 2019 全文链接
标题
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
作者
关键词
-
出版物
Frontiers in Genetics
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-25
DOI
10.3389/fgene.2019.00868
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Current Treatment Options in Neurology—SMA Therapeutics
- (2019) Megan A. Waldrop et al. Current Treatment Options in Neurology
- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- A guide to manufacturing CAR T cell therapies
- (2018) Philipp Vormittag et al. CURRENT OPINION IN BIOTECHNOLOGY
- Pegaptanib: choroidal neovascularization in patients with age-related macular degeneration and previous arterial thromboembolic events
- (2018) Maurizio Battaglia Parodi et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- CAR-T: trailblazing the path from clinical development to the clinic
- (2018) Samuele Butera GENE THERAPY
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety
- (2018) Maria Pia Cicalese et al. MOLECULAR THERAPY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- INVOSSA, a first-in-class of cell and gene therapy for osteoarthritis treatment: the phase III trial
- (2018) B. Lee OSTEOARTHRITIS AND CARTILAGE
- INVOSSA-K induces an anti-inflammatory environment in a rat mia model via macrophage polarization
- (2018) H. Lee et al. OSTEOARTHRITIS AND CARTILAGE
- Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives
- (2018) Marina França Dias et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- Gene therapy: evidence, value and affordability in the US health care system
- (2018) Grace Hampson et al. Journal of Comparative Effectiveness Research
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- The Natural History of Inherited Retinal Dystrophy due to Biallelic Mutations in the RPE65 Gene
- (2018) Daniel C. Chung et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- FDA approves patisiran to treat hereditary transthyretin amyloidosis
- (2018) Heather Wood Nature Reviews Neurology
- Voretigene neparvovec-rzyl for the treatment of biallelic RPE65 mutation–associated retinal dystrophy
- (2018) Stephen Russell et al. Expert Opinion on Orphan Drugs
- Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
- (2018) Charmaine A. Ramlogan-Steel et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Gene therapy for RPE65-related retinal disease
- (2018) Virginia Miraldi Utz et al. OPHTHALMIC GENETICS
- Health outcomes in spinal muscular atrophy type 1 following AVXS‐101 gene replacement therapy
- (2018) Samiah Al‐Zaidy et al. PEDIATRIC PULMONOLOGY
- Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease
- (2018) Vamshi K. Rao et al. Journal of Managed Care & Specialty Pharmacy
- Efficacy and safety of nusinersen in infants with presymptomatic spinal muscular atrophy (SMA): Interim results from the NURTURE study
- (2017) E. Bertini et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- AVXS-101 Phase 1 gene therapy clinical trial in SMA Type 1: Event free survival and achievement of developmental milestones
- (2017) Jerry R. Mendell et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Nusinersen for the treatment of spinal muscular atrophy
- (2017) Claudia A. Chiriboga Expert Review of Neurotherapeutics
- Spinraza—a rare disease success story
- (2017) V Prakash GENE THERAPY
- Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug
- (2017) Francesca Ferrua et al. HUMAN GENE THERAPY
- Transthyretin familial amyloid polyneuropathy: an update
- (2017) Violaine Plante-Bordeneuve JOURNAL OF NEUROLOGY
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
- (2017) Stephen Russell et al. LANCET
- Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL
- (2017) Zachary J. Roberts et al. LEUKEMIA & LYMPHOMA
- Viral vanguard: Designing cancer-killing viruses to chase metastatic tumors
- (2017) Shraddha Chakradhar NATURE MEDICINE
- Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
- (2017) David R Corey NATURE NEUROSCIENCE
- 2016 EMA drug approval recommendations
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): end of study results from the phase 3 CHERISH study
- (2017) E. Mercuri et al. NEUROMUSCULAR DISORDERS
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Invossa™ (TISSUEGENE-C) induces an anti-inflammatory environment in the arthritic knee joints via macrophage polarization
- (2017) K. Choi et al. OSTEOARTHRITIS AND CARTILAGE
- Chimeric antigen receptor T-cell therapy for glioblastoma
- (2017) Analiz Rodriguez et al. Translational Research
- Acute lymphoblastic leukemia: a comprehensive review and 2017 update
- (2017) T Terwilliger et al. Blood Cancer Journal
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Nusinersen for the treatment of spinal muscular atrophy
- (2017) Claudia A. Chiriboga Expert Review of Neurotherapeutics
- Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis
- (2017) Fabiola Escolano-Lozano et al. Brain and Behavior
- The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplant
- (2017) David L. Veenstra et al. JOURNAL OF MEDICAL ECONOMICS
- A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys
- (2017) Michael St. Andre et al. Skeletal Muscle
- CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes
- (2017) Eric Ehrke-Schulz et al. Scientific Reports
- Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
- (2016) Praveen K. Bommareddy et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
- (2016) James S. Butler et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research
- (2016) Christopher Strouse et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
- (2016) P. G. Richardson et al. BLOOD
- Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency
- (2016) Maria Pia Cicalese et al. BLOOD
- FDA approves new treatment of metastatic melanoma
- (2016) Carrie Printz CANCER
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
- (2016) Philippe Kerschen et al. Current Treatment Options in Neurology
- TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies
- (2016) David Adams et al. EXPERT OPINION ON PHARMACOTHERAPY
- How to select the best available related or unrelated donor of hematopoietic stem cells?
- (2016) J.-M. Tiercy HAEMATOLOGICA
- Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis
- (2016) Daniel Gaudet et al. HUMAN GENE THERAPY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial
- (2016) Jean Bennett et al. LANCET
- Considerations and challenges for patients with refractory and relapsed acute myeloid leukaemia
- (2016) Jonathan Kell LEUKEMIA RESEARCH
- Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice
- (2016) Cy A Stein MOLECULAR THERAPY
- Big win possible for Ionis/Biogen antisense drug in muscular atrophy
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials
- (2016) Eugenio Mercuri et al. NEUROMUSCULAR DISORDERS
- How to select the best available related or unrelated donor of hematopoietic stem cells?
- (2016) J.-M. Tiercy HAEMATOLOGICA
- Adenosine Deaminase Deficiency – More Than Just an Immunodeficiency
- (2016) Kathryn V. Whitmore et al. Frontiers in Immunology
- Clinical development of gene therapy: results and lessons from recent successes
- (2016) Sandeep RP Kumar et al. Molecular Therapy-Methods & Clinical Development
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Exon skipping therapy for Duchenne muscular dystrophy
- (2015) Ryszard Kole et al. ADVANCED DRUG DELIVERY REVIEWS
- Mipomersen, an Antisense Oligonucleotide to Apolipoprotein B-100, Reduces Lipoprotein(a) in Various Populations With HypercholesterolemiaSignificance
- (2015) Raul D. Santos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Haploidentical HSCT: a 15-year experience at San Raffaele
- (2015) C Bonini et al. BONE MARROW TRANSPLANTATION
- Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
- (2015) M Mohty et al. BONE MARROW TRANSPLANTATION
- Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
- (2015) F. J. Kohlhapp et al. CLINICAL CANCER RESEARCH
- Intracellular delivery of VEGF165 encoding gene therapeutic using trifunctional copolymers of ethylene oxide and propylene oxide
- (2015) Oksana Bondar et al. EUROPEAN POLYMER JOURNAL
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors
- (2015) Hinrich Abken Immunotherapy
- Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
- (2015) Douglas B Johnson et al. Immunotherapy
- pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia
- (2015) Roman V. Deev et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome Editing Technologies: Defining a Path to Clinic
- (2015) Jacqueline Corrigan-Curay et al. MOLECULAR THERAPY
- Spinal Muscular Atrophy Therapeutics: Where do we Stand?
- (2015) Constantin d’Ydewalle et al. Neurotherapeutics
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Tissuegene-C (INVOSSA™) in patients with osteoarthritis: A phase II trials
- (2015) J. Cho et al. OSTEOARTHRITIS AND CARTILAGE
- Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee
- (2015) J.J. Cherian et al. OSTEOARTHRITIS AND CARTILAGE
- Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides
- (2015) Umar Burki et al. Nucleic Acid Therapeutics
- Spinal Muscular Atrophy: Therapeutic Strategies
- (2014) Diana Castro et al. Current Treatment Options in Neurology
- Key points of basic theories and clinical practice in rAd-p53 (Gendicine™) gene therapy for solid malignant tumors
- (2014) Yi Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives
- (2014) Guang-Xia Chen et al. OncoTargets and Therapy
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside
- (2014) Valerie Ferreira et al. Frontiers in Immunology
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
- (2013) Chiara Zanetta et al. CLINICAL THERAPEUTICS
- Diagnosis and treatment of familial hypercholesterolaemia
- (2013) G. Kees Hovingh et al. EUROPEAN HEART JOURNAL
- Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK)
- (2013) Stuart J Moat et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?
- (2013) Monir Shababi et al. JOURNAL OF ANATOMY
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. MUSCLE & NERVE
- Lessons Learned from the Clinical Development and Market Authorization of Glybera
- (2013) Laura M. Bryant et al. Human Gene Therapy Clinical Development
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- (2012) Frederick J. Raal et al. ATHEROSCLEROSIS
- T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation
- (2012) L. Vago et al. BLOOD
- Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency
- (2012) A. Hassan et al. BLOOD
- Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B
- (2012) Stanley T. Crooke et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Mipomersen
- (2012) Daniel N. Ricotta et al. Cardiology in Review
- Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
- (2012) Evan A. Stein et al. CIRCULATION
- Gene therapy for lipoprotein lipase deficiency
- (2012) Daniel Gaudet et al. CURRENT OPINION IN LIPIDOLOGY
- Drug safety evaluation of defibrotide
- (2012) Paul G Richardson et al. Expert Opinion On Drug Safety
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
- (2012) Selim Corbacioglu et al. LANCET
- Stem cells in severe infantile spinal muscular atrophy
- (2012) Eugenio Mercuri et al. NEUROMUSCULAR DISORDERS
- Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy
- (2012) Mary P. McGowan et al. PLoS One
- Defibrotide Interferes With Several Steps of the Coagulation-Inflammation Cycle and Exhibits Therapeutic Potential to Treat Severe Malaria
- (2011) Ivo M.B. Francischetti et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
- (2011) Anne C. Goldberg et al. Journal of Clinical Lipidology
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial
- (2010) Paul G. Richardson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Rexin-G, a targeted genetic medicine for cancer
- (2010) Erlinda M Gordon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy
- (2010) Natalia N. Singh et al. RNA Biology
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA
- (2009) Virginia B Mattis et al. BMC NEUROSCIENCE
- Oral Administration of the Thyrotropin-Releasing Hormone (TRH) Analogue, Taltireline Hydrate, in Spinal Muscular Atrophy
- (2009) Zenichiro Kato et al. JOURNAL OF CHILD NEUROLOGY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
- (2009) Fabio Ciceri et al. LANCET ONCOLOGY
- Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
- (2009) Sant P Chawla et al. MOLECULAR THERAPY
- Introduction: Understanding the Role of Angiogenesis and Antiangiogenic Agents in Age-Related Macular Degeneration
- (2009) Susan B. Bressler OPHTHALMOLOGY
- Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100
- (2008) Rosie Z. Yu et al. BIOCHEMICAL PHARMACOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
- (2007) Tien Wong et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started